• Hims & Hers subsidiaries XeCare, Apostrophe Pharmacy entered a Master Receivables Purchase Agreement with JPMorgan on July 1, 2026.
• Facility allows sales of eligible receivables for cash, subject to a purchase discount; JPMorgan can decline any purchase.
• Facility limit set at USD 400 million; initial term 364 days with extensions up to one year each by written agreement.
• Hims & Hers signed a July 1, 2026 performance undertaking guaranteeing sellers’ obligations under the RPA, not receivable collectability.
• Amendment No. 4 to its revolving credit and guaranty agreement, signed June 26, 2026, permits the RPA structure and adds USD 400 million debt capacity.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Hims & Hers Health Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001773751-26-000146), on July 01, 2026, and is solely responsible for the information contained therein.